Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2003-09-29

DNA strand breaks induced by the anti-topoisomerase II bis-dioxopiperazine ICRF-193.

N Hajji, N Pastor, S Mateos, I Domínguez, F Cortés

Index: Mutat. Res. 530 , 35-46, (2003)

Full Text: HTML

Abstract

The bis-dioxopiperazine ICRF-193 has long time been considered as a pure topoisomerase II catalytic inhibitor able to exert its inhibitory effect on the enzyme without stabilization of the so-called cleavable complex formed by DNA covalently bound to topoisomerase II. In recent years, however, this concept has been challenged, as a number of reports have shown that ICRF-193 really "poisons" the enzyme, most likely through a different mechanism from that shown by the classical topoisomerase II poisons used in cancer chemotherapy. In the present investigation, we have carried out a study of the capacity of ICRF-193 to induce DNA strand breaks, as classical poisons do, in cultured V79 and irs-2 Chinese hamster lung fibroblasts using the comet assay and pulsed-field gel electrophoresis (PFGE). Our results clearly show that ICRF-193 readily induces breakage in DNA through a mechanism as yet poorly understood.